Podchaser Logo
Home
Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

Released Tuesday, 7th May 2024
Good episode? Give it some love!
Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

Tuesday, 7th May 2024
Good episode? Give it some love!
Rate Episode

In this episode, Contributing Editor Samuel Wilson, MD, an assistant professor of hematology at the University of North Carolina, Chapel Hill, talks with Marc Blondon, MD, an attending physician in the division of angiology and hemostasis with the University Hospitals of Geneva (Switzerland). They talk about a paper co-authored by Dr. Blondon titled, “Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives.” Dr. Wilson wrote about the study in a recent issue of The Hematologist.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features